The effects of oral administration of buprenorphine ('buprenorphine jello'), a partial~t opioid agonist, oral naltrexone, a~t antagonist and morphine, a J.1 agonist, were investigated in rats following laparotomy. Food and water consumption and body weight were reduced in rats that underwent surgery. Rats undergoing anaesthesia alone showed only a small reduction in water consumption. Administration of oral buprenorphine (0.5mg/kg in flavoured gelatin) decreased the effects of surgery on body weight and water intake when compared to untreated (vehicle alone) controls. The magnitude of this beneficial effect was similar to that seen in previous studies using subcutaneous administration of buprenorphine. The fall in body weight and food and water intake following surgery was similar in the groups which received morphine and the control group which received vehicle (jelly).
that surgery causes a depression in food and water consumption, a loss of body weight and a depression in activity. Administration of the analgesic agents nalbuphine, buprenorphine and carprofen reduces the depressant effects of surgery on some of these variables (Flecknell &. Liles 1991 , Liles &. Flecknell 1993a Flecknelll993bl. These actions of analgesics are not accounted for by the non-specific effects of these compounds in normal rats (Liles &. Flecknell 1992) . Buprenorphine, nalbuphine and carprofen have all been shown to have an analgesic effect using analgesiometric tests (Cowan et al. 1977a , Strub et al. 1982 , Bryant et al. 1983 , Errick &. Heel 1983 , Schmidt et al. 1985 , Baruth et al. 1986 , Staritz et al. 1986 . One explanation of the effects observed in rats following surgery is that surgery results in post-operative pain, and that the administration of analgesics alleviates that pain. This hypothesis assumes that the depression in activity, body weight and food and water consumption is caused by post-operative pain. An alternative hypothesis would be that some or all of these effects were due to endorphin production following surgery.
Endorphins are believed to modulate pain sensation, although their exact role in the perception and control of pain remains unclear (Woolf &. Wall 1983 , Herz &. Millan 1990 , Ramabadran &. Bansinath 1990 . Pain itself and/or stress may lead to analgesia by inhibition of nociceptive afferent inputs to the dorsal horn of the spinal cord, and this inhibition is thought to be endorphin mediated (Basbaum &. Fields 1984) .
Opioids have actions at a number of distinct receptors. Analgesic effects are produced primarily at II (mul and K (kappa) receptors. Endogenous opioids with analgesic effects are believed to act primarily at J1 receptors. Nalbuphine and buprenorphine, the opioids shown in previous studies to have positive effects following surgery (Flecknell &. Liles 1991, Liles &. Flecknelll993a) have the potential to reverse some actions of endogenous opioids. Nalbuphine is a J1 antagonist and K agonist (£Irick &. Heel 1983 , Schmidt et al. 1985 , and buprenorphine is a partial II agonist (Cowan et al. 1977b , Heel et al. 1979 , Flecknell et al. 1989 ) which dis- Liles et al. places pure J1 agonists from J1 receptors [Latasch 1984 , Flecknell et al. 1989 . It is possible, therefore, that the reversal of endogenous opioids, which had been released in response to surgery, could be responsible for the positive effects of nalbuphine and buprenorphine on food and water consumption. Although the NSAID carprofen has been shown to have positive effects following surgery, and these are most unlikely to be mediated via endorphins, the magnitude of the effect of this analgesic was significantly less than that of buprenophine (Liles &. Flecknell1993a) . It remains possible, therefore, that the effects of buprenorphine are related to its antagonist, rather than agonist, effects.
To test the hypothesis that the postoperative effects seen following administration of nalbuphine and buprenorphine were due to the antagonist effects, not the agonist actions, of these agents, the specific J1 antagonist naltrexone was administered to rats following surgery. A positive effect of naltrexone would support the hypothesis that endogenous opioid production was responsible for the depressant effects seen after surgery, and that reversal of these effects, rather than an analgesic action, was the mode of action of the analgesics studied. The implications for post-operative pain assessment are considerable, since if this alternative hypothesis were correct, then signs which had previously been assumed to indicate the presence of pain would require re-interpretation.
The main investigation of the effects of naltrexone following laparotomy was preceded by an initial investigation to establish an appropriate dose of this opioid antagonist, by assessing its ability to antagonize the analgesic effects of the J1 agonist fentanyl.
Effects of oral buprenorphine
In addition to assessing the effects of naltrexone, an alternative dosing regimen for buprenorphine was also studied. Oral buprenorphine ('buprenorphine jello') has been suggested as an effective and stress-free means of administering this analgesic to rats (Pekow 1992), however, the efficacy of this analgesic regimen as a means of controlling post-operative pain has not been determined.
Effects of morphine
A further objective of this study was to assess whether a single dose of morphine could provide clear beneficial effects following surgery, since use of shorter-acting opioids such as morphine is common clinical practice in a number of establishments.
In order to develop and refine the methods used to assess the effects of surgery, the animals' behaviour was characterized in more detail, in contrast to the simple index of total locomotor activity which we have used in previous studies.
Materials and methods

Naltrexone and endogenous opioids: preliminary study
Male Wistar outbred rats, weighing 200 g, obtained from this Institute's Specific Pathogen Free Unit were used. The animals were housed in a rOOlTI which was remote from the main area of the animal unit to avoid disturbances as a result of external factors. Room temperature was controlled at 20 ± 2°C. A 9h: ISh light-dark cycle was maintained, the room lighting was automatically switched on at 08:00 h and off at 17:00h. Animals received a commercial pelleted diet (R and M No I, SDS Ltd, Essex, England) and water ad libitum. Naltrexone was administered by adapting the method developed by Peckow (19921.Jelly solutions were made by dissolving one packet of gelatin (blackcurrant flavour, Tescos) in 200 ml of warm water. Jelly solutions were prepared 24 h before use and stored in a refrigerator (3-5°C). When set, a measured volume of jelly (2ml) was given to each rat. After 2 days of administration once per day, rats ate the jelly pellet as soon as it was placed in their cage. Treated jelly was prepared by dissolving 200 mg of crushed naltrexone (4 x 50 mg tablets, Nalorex, Du Pont) in 200 ml of cool blackcurrant jelly solution.
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On the days of treatment, at 14:00h, rats received either untreated jelly In = 5) or jelly containing naltrexone (2mg total dose, equivalent to 10mg/kg body weightl (n = 5). Animals were randomly assigned to either the naltrexone or control groups. Rats were observed to ensure that all of the treated jelly pellet was consumed. At 15:00h, all rats received 0.8 ml/kg i.p. of fentanyl/fluanisone (Hypnorm, Janssen; 250 J1g/kgfentanyl). Body temperature was maintained using a thermostatically controlled heating pad (Harvard Apparatus Ltd). Following the onset of sedation, the degree of analgesia was assessed using a tail pressure analgesiometer (Arnol R Horwell Ltd). The end-point of the assessment was either a movement of the tail or of another part of the body. The maximum pressure applied was limited to avoid causing any permanent tissue damage. Assessments were repeated every 15min for one hour. At the conclusion of the test procedure, animals were placed in an incubator for one hour before being returned to their home cage. This procedure was repeated on four subsequent occasions, with the fentanyl/fluanisone administered 2, 4, 6 or 8 h after naltrexone administration. A minimum of 5 days elapsed between treatments. The analgesiometric scores of the naltrexone and control groups were compared at each of the five time points using a Mann-Whitney test, using the statistical software package SPSS ISPSSInc).
Main study, all groups
Male Wistar outbred rats, weighing 200-250 g, obtained from this Institute's Specific Pathogen Free Unit were used. The animals were housed under the same conditions as described in the preliminary study. Additionally, two anglepoise lights fitted with 40 W red bulbs were illuminated continuously, and these enabled recording of the rats' behaviour during the 15h dark period, using a CCTV video camera. (WV-BL200, Turners) connected to a time lapse video recorder IPanasonic AG 6024, Turners). Animals underwent a minimum of 7 days period of acclimatization to single housing and daily handling and weighing prior to study. Food Activity Description Table 1 Categories of behaviour used in study Group 1: 2ml cube of jelly, followed by halothane anaesthesia and a midline laparotomy (surgery group, n = 10).
Group 2: 2 ml cube of jelly containing naltrexone (10mg/kg body weight) followed by halothane anaesthesia and a midline laparotomy (naltrexone/surgery group, n=lO).
Group 3: 2 ml cube of jelly containing buprenorphine (0.5mg/kg body weightl followed by halothane anaesthesia and a midline laparotomy (buprenorphine/surgery group, n = 10). and water consumption, body weight and activity were recorded for a minimum of 3 days: the day before treatment, the day of treatment, and the following day. Food and water consumption were monitored by weighing the animals' food hoppers and water bottles between 09:00 hand 10:00h each morning, when they were replenished. The videotapes were subsequently replayed and the rats' behaviour was recorded every lOs for one minute (six observations) every 15 min throughout the whole of the 15h dark phase of the light cycle. Following a preliminary study (Liles 1994) , nine categories were used to record the rats' behaviours ( Table 1) .
The study was conducted in two stages. The first part involved 40 animals, allocated to four treatments using a randomized block design. All of these animals underwent a midline laparotomy under general anaesthesia:
The second part of the study comprised 40 unoperated animals allocated to four treatments using a randomized block design:
All groups received the relevant treatment at 14:00h. As in the preliminary study, the oral dosed animals had received untreated jelly on the preceding 2 days to ensure that all of the jelly was consumed rapidly. One hour later (15:00h) the animals underwent halothane anaesthesia (induction, 4% halothane in oxygen, maintenance 2% halothane) for 14min. Surgery groups (1-4) also underwent a midline laparotomy, with gentle manipulation of the viscera. Full details of the procedure have been described elsewhere (Liles & Flecknell1993b) . After completion of anaesthesia or anaesthesia/surgery the rats were placed in an incubator maintained at 35°C for approximately 30 min before being returned to their home cages.
Statistical analysis
Body weight and food and water consumption were calculated for the operated and control treatment groups. In order to determine whether these changes were significantly different from pre-treatment means, Student's paired t-tests were performed on the data. The difference between treatment Group 4: morphine sulphate (International Medical Systems), 5 mg/kg s.c., followed by halothane anaesthesia and a midline laparotomy (morphine/surgery group, n = 10).
Group 5: 2 ml cube of jelly, followed by halothane anaesthesia (vehicle alone control group, n = 10).
Group 6: 2 ml cube of jelly containing naltrexone (10mg/kg body weight) followed by halothane anaesthesia (naltrexone control group, n = 10).
Group 7: 2 ml cube of jelly containing buprenorphine (0.5mg/kg body weight) followed by halothane anaesthesia (buprenorphine control group, n = 10).
Group 8: morphine sulphate (International Medical Systems), (5mg/kg) s.c., followed by halothane anaesthesia (morphine control group, n = 10). groups was tested using one-way analysis of variance. Following analysis of variance, the naltrexone/ surgery, buprenorphine/ surgery and morphine/surgery groups were each compared with the control/surgery group using the pooled estimate of variance as described by Armitage and Berry (19871. Activity data were divided into 3 time blocks: the first 5h of darkness, the second 5 h and the 5 h prior to the start of the light phase of the animals' photoperiod. Total time spent in each activity over the whole of the dark phase of the photoperiod was also calculated. Activity was analysed by one-way analysis of variance to determine whether there was a treatment effect, and Student's paired t-test used to compare pre-and posttreatment values. In view of the multiple comparisons made, a P value of < 0.005 was considered significant. One-way ANOVA was used to determine whether there was any variation between treatment groups in their pre-treatment data. The between groups variation was investigated for each behaviour using Canonical Discriminant Analysis. Analyses were performed using the statistics program SPSS /SPSSInc). 
Results
Naltrexone and endogenous opioids: preliminary study
The results of each rat's analgesiometer scores at the various time points is shown in Fig 1. Analgesiometer scores were significantly different between naltrexone treated and control groups (P < 0.01) at 1, 2, 4, 6 and 8h.
Main study
Mean changes in body weight and food and water intake following anaesthesia and surgery or anaesthesia alone together with one of the four treatments are shown in Figs 2a-c. These figures also include the results of the statistical analyses. Following surgery all 4 treatment groups showed significant reductions in body weight (P < 0.01) and food (P < 0.005) and water (P < 0.01) intake. When operated and unoperated groups treated with the same regimen were compared a significant reduction in body weight and water intake was observed in all of the operated groups (P < 0.005). A significant reduction in food intake [P < 0.005) was seen in all four of the control groups (anaesthesia and treatment alone). Table 2 summarizes the comparisons of activity data in the operated and unoperated groups receiving each of the drug treatment regimens. A summary bar chart displaying the relative amount of time spent performing each activity, throughout the dark phase of the photoperiod, before and after treatment is shown in Fig 3 .
Control-treated (felly alone) animals
Body weight and food intake were not significantly affected following jelly and halothane anaesthesia, but water intake was significantly reduced (P < 0.005). Following surgery body weight, and food and water intake were all significantly depressed (P < 0.005). The main effects on behaviour of halothane anaesthesia were to reduce the time spent asleep, and to reduce the time spent eating. Animals which received jelly and underwent surgery spent more time (Table 2) .
Naltrexone-treated animals
The un operated control group treated with naltrexone had a significant reduction in food IP < 0.005) and water IP < 0.01) intake. Significantly greater reductions in body weight and food and water intake were seen in naltrexone-treated animals that underwent surgery, in comparison to naltrexone and anaesthesia alone. The naltrexone un operated control group showed a similar activity pattern to that observed in the jelly unoperated control group. Animals spent more time asleep and less time on other activities throughout the dark phase of their photoperiod. Following surgery, the scores for licking were significantly greater (P < 0.0011 and the grooming score significantly reduced (P < 0.001) in one or more time periods compared to pre-surgery activities ( Table 2 ). Comparison of activity over the whole of the dark period in operated and unoperated groups showed that licking scores were significantly greater (P < 0.001) and the grooming scores significantly reduced (P < 0.001) in the operated group than the unoperated control group treated with naItrexone.
Oral buprenorphine-treated animals
Unoperated controls treated with oral buprenorphine had a significant reduction in food intake (P < 0.0051. Following surgery and buprenorphine treatment body weight IP < 0.01) and food IP < 0.005) and water (P < 0.01) intake were all significantly reduced. There was no significant difference in food intake between the operated and unoperated buprenorphine-treated animals. Following a control period of anaesthesia the most substantial changes in the relative amount of time spent on each activity were seen in the buprenorphine treatment group. Asleep scores decreased and sitting, grooming, exploring and running scores increased significantly IP < 0.051 during at least one of the time periods investigated. When the posttreatment differences in the scores of both operated and non-operated groups were compared the asleep and licking scores were significantly greater (P < 0.005) and the grooming and exploring scores were significantly smaller (P < 0.002) in the operated group treated with buprenorphine (Table 2) .
Morphine-treated animals
The unoperated control group treated with morphine showed a small but statistically significant (P < 0.01) reduction in weight following treatment. Larger reductions in body weight and food and water consumption were seen in the rats which underwent surgery and received morphine, when compared to the un operated morphine control group IP < 0.005). No significant differences were found between the reduction in body weight after surgery in the morphine and jelly (vehicle alone) groups (0.1 > P> 0.05). Following a single dose of morphine and halothane anaesthesia, rats spent significantly more time asleep than before treatment. In the operated group which received morphine, the rats spent more time asleep and licking and less time grooming than before surgery. The total ('all-night'l differences in scores in the operated and unoperated morphine groups showed significantly greater licking scores (P < 0.001) and decreased grooming (P < 0.001) in the operated group. Table 3 shows the results of one-way analysis of variance testing for differences between the four different drug treatments in the operated and non-operated groups at all the time blocks studied. Treatment was a significant factor in the differences observed in asleep scores for operated and unoperated groups at all the time blocks studied. Treatment was a significant factor in variation of sitting scores for the unoperated control groups at each of the time blocks. Treatment group was also significant for sitting scores during the first and third 5 h blocks.
Canonical discriminant analysis
Canonical discriminant analysis of behavioural data produced no significant discriminant functions for pre-treatment behavioural data. Following treatment, analysis of the eight groups produced two functions which contributed significantly (P < 0.0011 to the between group variance at Treatment with jelly (control), morphine (5 mg/kg s.c.),buprenorphine in jelly (0.5 mg/kg) or naltrexone in jelly (10 mg/kg). Values are P values. t indicates operated animals had a greater score for that activity . .J. indicates that operated animals had a smaller score for that activity all three time periods, and also for the total period of observation. The results of this latter analysis are displayed in Fig 4. The behaviours with the greatest contribution to each of the canonical functions were licking (function 1) and asleep (function 2Ji behaviours which had also been shown to vary significantly between groups using ANOVA.
Discussion
This study was undertaken to verify the results of previous studies (Flecknell &. Liles . 1987) . Currently, naltrexone is only available in the UK as an oral formulation. Studies in man have demonstrated that naltrexone is absorbed rapidly and completely from the gut, but is subject to 95 % pre-systemic first-pass metabolism in the liver (Dollery 19911. Comparable data for naltrexone metabolism in rats are not available, but data for other opioids in rats suggest a similarly high liver metabolism following oral administration. The LD50 of naltrexone in rats and mice is 551-586mg/kg (Budavari 1989 , Sax & Lewis 1989 . Assuming a similar high liver first-pass extraction in rats as in man, an oral dose of 10 mg/kg was selected as phine; and the efficacy of oral administration of buprenorphine was evaluated .
The value of behavioural observations in detecting post-surgical disturbance was investigated using commonly used statistical techriiques in addition to canoJilical analysis. by analysis of the total frequencies of each of the nine behaviour categories over the whole of the dark phase of the rats' photoperiod. Animals were treated with jelly (Con), buprenorphine in jelly (0.5 mg/kg) (Bup), naltrexone in jelly (10 mg/kg) (Nalt) or morphine (5 mg/kg, s.c.) (Mar) one hour before anaesthesia, and either underwent a control period of anaesthesia (fAnaesth) or laparotomy and visceral manipulation (/Surg). o Nalt/Surg; 0 Bup/Surg; t::. MorlSurg; 0 Con/Surg; • Nalt/Anaesth; • Bup/Anaesth; A Mor/Anaesth; • Con/Anaesth a potentially safe and effective dose rate. Results of analgesiometry demonstrated that this dose of naltrexone significantly reduced the analgesic effect of high doses of fentanyl (250JIg/kg) for at least 8 h, supporting the view that this dose rate was likely to reduce endogenous opioid peptide activity.
If the effects of endogenous opioid pep tides are reduced or abolished by pre-treatment with naltrexone, three possible effects could be observed following surgery: la) Food and water intake and body weight decrease more than in untreated (vehicle alone) animals. This would imply that endogenous opioid peptide production reduces the severity of the effects of surgery on these parameters. (b) Food and water intake and body weight decrease less than in untreated (vehicle alone) animals. This would imply that the depressant effects of surgery are in part due to endorphin production, and previous studies demonstrating an apparent beneficial effect of opioids were due to antagonism of endorphin activity. (c) Food and water intake and body weight do not differ significantly in comparison with untreated (vehicle alone) treated animals. This would imply that endogenous opioids do not significantly influence the variables measured in this model of clinical pain.
In the present study, neither the magnitude of the fall in body weight, and food and water intake, nor the behavioural scores differed between naltrexone and control (vehicle alone) rats following surgery. This implies that endorphins do not significantly affect the variables measured in this model, and that the beneficial effects of buprenorphine and nalbuphine reported previously cannot be explained by J.1 receptor antagonist activity of these opioids.
Effects of the JI-opioid agonist, morphine
The administration of morphine has potential advantages in comparison with buprenorphine since, unlike buprenorphine, it does not exhibit a ceiling effect with regard to analgesic activity (Cowan et a1. 1977a , Cowan et a1. 1977b ).If severe post-operative pain occurs, Liles et al. buprenorphine might not provide sufficient analgesia, even at high dose rates, whereas high dose morphine could be effective. An important practical consideration is that morphine has a relatively short duration of action in comparison to buprenorphine (Cowan et a1. 1977a . Provision of prolonged analgesia would therefore require repeated doses of morphine. In the rat, the duration ofpost-operative pain has not, however, been established, and it is possible that a single dose of a potent opioid could be of benefit. Results of the present study do not support this view, however. The fall in body weight and food and water intake following surgery was similar in the groups which received morphine and the control group which received vehicle (jelly)alone. Unoperated controls treated with morphine had significantly decreased feeding and increased sleeping scores in comparison to pre-treatment values. The behaviour patterns were also similar in morphine and vehicle alone groups.
The analgesic effect of morphine is estimated to be only 2-3 h in rats (Flecknell1984). In the present study, food and water intake and body weight changes were measured over 24 h periods. Any short beneficial effects of morphine may therefore have been masked by subsequent changes after cessation of its analgesic action. In order to establish possible beneficial effects, repeated dosing or use of slow-release preparations would be required. What is clear is that administration of a single dose of a potent but relatively short-acting opioid does not provide the apparent beneficial effects seen following longer-acting analgesics such as buprenorphine.
Effects of oral buprenorphine
Administration of oral buprenorphine decreased the effects of surgery on body weight and water intake when compared to untreated (vehicle alone) operated controls. Similar results have been obtained using buprenorphine (0.05mg/kg) administered by subcutaneous injection in previous studies (Liles &. Flecknell 1993a , Liles &. Flecknell 1993b .In unoperated controls, buprenorphine caused a marked decrease in food intake, but had no significant effect on water intake or body weight. These effects are similar to those seen in previous studies of the effect of subcutaneous administration of buprenorphine tu unoperated rats (Liles &. FlecknelI1992 ). These previous studies indicated that the depressant effects on food intake were dose dependent. It is possible that use of lower doses of buprenorphine might produce less depressant effects in unoperated animals, while still providing effective analgesia when required. It would therefore be useful to evaluate the effects of different dose rates of analgesic in this model of post-surgical pain. Because of the effects on behaviour, notably a decrease in time spent asleep, in unoperated controls, it is difficult to interpret the effects of buprenorphine on behaviour following surgery.
Effects of vehicle (jelly)
It is possible that administration of jelly may have affected the results obtained in this study. Dietary variables have been shown to influence pain sensitivity both before and after analgesic administration, but the exact effects of dietary changes remain unclear. Holder (1988) and Holder and Bolger (1988) report that intake of sweetened water reduced pain threshold in rats, however another study reported no effect of feeding saccharin, sucrose or fat (Kanarek et al. 1991) .These studies all allowed continual access to the novel dietary element for at least 14 days prior to testing. In comparison to these studies both the total quantity of sucrose and duration of treatment used in our investigations were small. It therefore seems unlikely that feeding jelly cubes would affect pain thresholds.
Canonical discriminant analysis
Canonical discriminant analysis is a technique for reducing the dimensionality of a data set. If large numbers of variables are measured in an individual (e.g. nine categories of behaviour) then it is possible that some of these variables are highly correlated with each other, and that one may be predicted from another. Canonical discriminant analysis aims to produce new, derived variables (canonical functions) from a number of the original measured variables. These new variables are calculated to best distinguish between different treat-159 ment groups. The procedure can therefore produce a few new variables that describe the differences between the treatment groups, and so can provide a clearer summary of between group differences. An examination of the plot of the two functions in Fig 4 provides a useful overview of the changes in behaviour. Two clusters of groups can be seen. Overall, there is clear separation of the surgery and non-surgery groups. There is also a clear differentiation of groups that received buprenorphine from other treatment groups. The magnitude of this effect has important implications for the use of behavioural observations in pain scoring schemes, and this is discussed below.
General conclusions
The results of the present study support the hypothesis advanced in our previous investigations that the depressant effects of surgery are related to post-surgical pain and/or stress, and that the effects of analgesics are mediated by a reduction in pain, rather than by antagonism of endogenous opioids. The use of single doses of potent analgesics such as morphine does not seem likely to provide analgesia for a sufficient period of time to be of significant benefit to rats following surgical procedures. In contrast, oral administration of buprenorphine appears as effective as subcutaneous administration (as judged by the amelioration of the effects of surgery on food and water consumption and body weight seen in previous studies), and offers a simpler, less stressful means of drug administration. This alternative route of analgesic administration is particularly useful when no assistance is available to restrain animals for injection. In any event, it seems logical to conclude that firm physical restraint of an animal with a surgical wound may cause transient acute pain, that would not occur if the analgesic were presented as a palatable oral preparation, which is consumed voluntarily. Use of small pellets avoids the expense associated with medication of the drinking water or food, and allows much better control of the dose rate. A further possible refinement, to allow repeated administration of an analgesic, would be to provide automated dispensing of the jelly pellets.
Our attempt to compare the behaviour of rats following surgery clearly highlighted the problems associated with this approach to pain assessment. It has been generally assumed that animals in pain change their behaviour (Morton & Griffiths 1985 , National Research Council 1992 and this assumption has been incorporated into definitions of animal pain (Zimmerman 1986 ). If it is accepted that untreated rats will experience pain following surgery, then the present study does illustrate that behavioural changes occur. Behavioural changes occur following anaesthesia alone but use of canonical discriminant function plots enables this to be distinguished from the effects of surgery. The major confounding effect is the influence of buprenorphine on behaviour in normal rats. Many attempts at developing pain scoring systems use behavioural observations, often of a fairly simple and relatively subjective nature (Leese et aI. 1988 , Reid & Nolan 1991 , Thompson & Johnson 1991 , Fonda 1993 )and the effects of administration of the analgesic alone to normal animals were not evaluated in these studies. If the analgesics used had any major behavioural effects, then this may frustrate efforts at pain scoring using these criteria. Two possible approaches can be suggested to resolve this difficulty. Although the present study used more detailed behavioural analysis in comparison to our previous investigations (Flecknell & Liles 1992 Fiecknell1993bj the number of behaviour categories used was relatively small (9).In addition, the time-lapse video restricted the detailed analysis of some behaviours. Use of a larger number of behavioural categories might enable the effects of buprenorphine in normal rats to be distinguished from the effects of surgery. This could enable a set of behaviours to be developed that could discriminate between non-specific drug effects and the effects of the analgesic on surgically induced behavioural changes. These latter behaviours may be those which most closely predict the presence of post-operative pain. A second approach is to investigate the use of NSAIDs. These analgesics have significant effects following surgery (Liles & Flecknell 1993a )and would be predicted to have minimal behavioural modifying effects in normal animals. Use of these analgesics might enable development of behavioural scoring that could be applied with confidence for post-operative pain evaluation. cology 60, 537-45 Dodman NH, Shuster L, Court MH, Dixon R (1987) Investigation into the use of narcotic antagonists in the treatment of a stereo typic behavior pattern (crib-biting) in the horse. 
